These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 31416571)

  • 21. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
    Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
    Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy: paving a new avenue for cancer research.
    Kurma K; Eslami-S Z; Alix-Panabières C; Cayrefourcq L
    Cell Adh Migr; 2024 Dec; 18(1):1-26. PubMed ID: 39219215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.
    Koeppel F; Blanchard S; Jovelet C; Genin B; Marcaillou C; Martin E; Rouleau E; Solary E; Soria JC; André F; Lacroix L
    PLoS One; 2017; 12(11):e0188174. PubMed ID: 29161279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Value of Cell-Free Circulating DNA Profiling in Patients with Skin Diseases.
    Ma J; Teng Y; Youming H; Tao X; Fan Y
    Methods Mol Biol; 2023; 2695():247-262. PubMed ID: 37450124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 26. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell free DNA: revolution in molecular diagnostics - the journey so far.
    Nandi K; Verma R; Dawar R; Goswami B
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid biopsy: a holy grail for cancer detection.
    Sorbara L; Srivastava S
    Biomark Med; 2019 Aug; 13(12):991-994. PubMed ID: 31464153
    [No Abstract]   [Full Text] [Related]  

  • 30. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms.
    Grabuschnig S; Bronkhorst AJ; Holdenrieder S; Rosales Rodriguez I; Schliep KP; Schwendenwein D; Ungerer V; Sensen CW
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer.
    Bu J; Lee TH; Jeong WJ; Poellmann MJ; Mudd K; Eun HS; Liu EW; Hong S; Hyun SH
    PLoS One; 2020; 15(12):e0242145. PubMed ID: 33264292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
    Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
    Gai W; Sun K
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
    Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
    Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma.
    Shetti D; Mallela VR; Ye W; Sharif M; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Crit Rev Oncol Hematol; 2024 Aug; 200():104391. PubMed ID: 38795877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.